These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2783611)

  • 41. In vitro hepatic biotransformation of moclobemide (Ro 11-1163) in man and rat.
    Vallès B; Coassolo P; De Sousa G; Aubert C; Rahmani R
    Xenobiotica; 1993 Oct; 23(10):1101-11. PubMed ID: 8259692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
    Ulus IH; Maher TJ; Wurtman RJ
    Biochem Pharmacol; 2000 Jun; 59(12):1611-21. PubMed ID: 10799660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.
    Hamadjida A; Nuara SG; Kwan C; Frouni I; Bédard D; Gourdon JC; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2157-2164. PubMed ID: 32621059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of lifelong treatment with MAO inhibitors on amino acid levels in rat brain.
    Strolin Benedetti M; Kettler R; Marrari P; Cini M; Da Prada M; Dostert P
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):239-48. PubMed ID: 2078306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
    Waldmeier PC; Stöcklin K
    Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
    Finberg JP
    Acta Psychiatr Scand Suppl; 1995; 386():8-13. PubMed ID: 7717096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical aspects of the pharmacology of moclobemide. The implications of animal studies.
    Callingham BA
    Br J Psychiatry Suppl; 1989 Oct; (6):53-60. PubMed ID: 2619973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice.
    Miura H; Naoi M; Nakahara D; Ohta T; Nagatsu T
    Pharmacol Biochem Behav; 1996 Feb; 53(2):469-75. PubMed ID: 8808160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset.
    Hamadjida A; Nuara SG; Frouni I; Kwan C; Bédard D; Gourdon JC; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2139-2144. PubMed ID: 32601846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Species-specific biotransformation of moclobemide: a comparative study in rats and humans.
    Schoerlin MP; Da Prada M
    Acta Psychiatr Scand Suppl; 1990; 360():108-10. PubMed ID: 2248061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential type A inhibition, in healthy volunteers and depressive patients.
    Gasic S; Korn A; Eichler HG; Oberhummer I; Zapotoczky HG
    Eur J Clin Pharmacol; 1983; 25(2):173-7. PubMed ID: 6628500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.
    Mayersohn M; Guentert TW
    Clin Pharmacokinet; 1995 Nov; 29(5):292-332. PubMed ID: 8582117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
    Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
    J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.
    Villarinho JG; Fachinetto R; de Vargas Pinheiro F; da Silva Sant'Anna G; Machado P; Dombrowski PA; da Cunha C; de Almeida Cabrini D; Pinto Martins MA; Gauze Bonacorso H; Zanatta N; Antonello Rubin M; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):31-9. PubMed ID: 22525823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The action of befol and its derivatives on monoamine oxidase of different origins].
    Gol'dina OA; Moskvitina TA; Gankina EM; Kirkel' AZ; Kamyshanskaia NS; Lopatina KI; Sokolova TV; Zagorevskiĭ VA; Val'dman AV; Gorkin VZ
    Biull Eksp Biol Med; 1991 Mar; 111(3):279-80. PubMed ID: 2054504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.